Aminosalicylic acid: Difference between revisions
Gerald Chi (talk | contribs) m (→Overview) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 2: | Line 2: | ||
{{Aminosalicylic acid}} | {{Aminosalicylic acid}} | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
{{SK}} ''para''-aminosalicylic acid, ''p''-aminosalicylic acid or 4-aminosalicylic acid; abbreviated 4-ASA, or PAS | |||
==Overview== | ==Overview== | ||
Aminosalicylic acid is an [[antibiotic]] used to treat [[tuberculosis]]. It has been use for over forty years in the treatment of [[inflammatory bowel disease|inflammatory bowel disease (IBD)]], where it has shown greater potency in [[Crohn's disease]]. It is thought to act via [[NF-kB|NF-κB (nuclear factor-kappa B)]] inhibition and [[free radical]] scavenging. | |||
Aminosalicylic acid | |||
Aminosalicylic acid is sold in the [[United States]] by [[Jacobus Pharmaceutical]] as PASER<sup>®</sup>. | Aminosalicylic acid is sold in the [[United States]] by [[Jacobus Pharmaceutical]] as PASER<sup>®</sup>. | ||
Revision as of 22:05, 25 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Synonyms and keywords: para-aminosalicylic acid, p-aminosalicylic acid or 4-aminosalicylic acid; abbreviated 4-ASA, or PAS
Overview
Aminosalicylic acid is an antibiotic used to treat tuberculosis. It has been use for over forty years in the treatment of inflammatory bowel disease (IBD), where it has shown greater potency in Crohn's disease. It is thought to act via NF-κB (nuclear factor-kappa B) inhibition and free radical scavenging.
Aminosalicylic acid is sold in the United States by Jacobus Pharmaceutical as PASER®.
Mesalazine (5-aminosalicylic acid) is a closely related compound that also has medical uses.
Category
Antimycobacterial
US Brand Names
PASER®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
Mechanisms of Action
Aminosalicylic acid is an analogue of para-aminobenzoic acid (PABA) and acts as a competitive inhibitor of dihydropteroate synthase 1 (folP1). Its competitive antagonism with PABA is similar to the action of sulfonamides which disrupts biosynthesis in sensitive organisms. Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis. It inhibits the onset of bacterial resistance to streptomycin and isoniazid. Other mechanism of action has been postulated to be inhibition of synthesis of the cell wall component, mycobactin, thus reducing iron uptake by M. tuberculosis.